Cite
Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
MLA
Varia, M. A., et al. “Pimonidazole: A Novel Hypoxia Marker for Complementary Study of Tumor Hypoxia and Cell Proliferation in Cervical Carcinoma.” Gynecologic Oncology, vol. 71, no. 2, Nov. 1998, pp. 270–77. EBSCOhost, https://doi.org/10.1006/gyno.1998.5163.
APA
Varia, M. A., Calkins-Adams, D. P., Rinker, L. H., Kennedy, A. S., Novotny, D. B., Fowler, W. C., Jr, & Raleigh, J. A. (1998). Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecologic Oncology, 71(2), 270–277. https://doi.org/10.1006/gyno.1998.5163
Chicago
Varia, M A, D P Calkins-Adams, L H Rinker, A S Kennedy, D B Novotny, W C Fowler Jr, and J A Raleigh. 1998. “Pimonidazole: A Novel Hypoxia Marker for Complementary Study of Tumor Hypoxia and Cell Proliferation in Cervical Carcinoma.” Gynecologic Oncology 71 (2): 270–77. doi:10.1006/gyno.1998.5163.